Medical Center 1 Sevlievo EOOD

At Medical Center 1 Sevlievo EOOD, research in immune system diseases focuses on complex autoimmune conditions such as systemic lupus erythematosus, rheumatoid arthritis, and axial spondyloarthritis. These studies are designed to assess new treatments, compare them with existing options, and better understand how to control inflammation and disease activity.

• Evaluation of new therapies for systemic lupus erythematosus and related autoimmune disorders
• Studies in rheumatoid arthritis aimed at improving symptom control and treatment response
• Research in axial spondyloarthritis to test effectiveness of emerging anti-inflammatory medicines

The site contributes to clinical research that may help expand treatment choices for patients living with long-term autoimmune disease.

Clinical trials in respiratory tract diseases at this hospital/clinic include asthma, chronic obstructive pulmonary disease, and chronic bronchitis. The main goal is to evaluate therapies that may improve breathing, reduce flare-ups, and support better long-term disease control.

• Testing new approaches for asthma management and symptom relief
• Research in COPD and chronic bronchitis to reduce exacerbations and improve lung function
• Assessment of add-on treatments for people with persistent respiratory symptoms despite standard care

These studies reflect a strong focus on improving everyday respiratory health for patients with chronic airway disease.

The site is also active in virus diseases research, with trials involving COVID-19, influenza, respiratory syncytial virus, and human metapneumovirus. This work includes both treatment studies and vaccine research aimed at preventing infection or reducing the severity of illness.

• Evaluation of antiviral treatments for COVID-19 in people at risk of severe disease
• Studies of vaccines for influenza and respiratory viral infections in older adults
• Research on therapies that may limit progression of RSV and related viral infections

Overall, the research aims to improve protection against common and potentially serious viral illnesses across different age groups.

In skin and connective tissue diseases, the clinical program includes studies in cutaneous lupus erythematosus and related autoimmune skin conditions. These trials are focused on reducing skin inflammation, improving visible disease signs, and helping patients who have not responded well to standard treatments.

• Research on new options for subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus
• Evaluation of treatments for patients with both skin and systemic features of lupus
• Studies aimed at improving disease control when common therapies are not enough

This area highlights the center’s interest in autoimmune skin disease and the search for better symptom relief.

Research in digestive system diseases includes studies of ulcerative colitis, a chronic inflammatory condition of the bowel. The trials are intended to evaluate whether new treatment approaches can help patients reach remission and maintain better control of bowel symptoms.

• Clinical research on therapies for ulcerative colitis
• Assessment of treatment effectiveness in reducing intestinal inflammation
• Work aimed at improving remission rates and patient quality of life

This adds a gastrointestinal focus to the site’s broader portfolio of inflammatory disease research.

The musculoskeletal diseases portfolio at Medical Center 1 Sevlievo EOOD includes inflammatory joint and spine conditions, especially rheumatoid arthritis and axial spondyloarthritis. The studies are designed to compare therapies and measure how well they reduce pain, stiffness, and overall disease activity.

• Trials focused on rheumatoid arthritis symptom improvement and treatment response
• Research in axial spondyloarthritis to support better disease control
• Comparative studies of new medicines against current standard treatments

This area shows a consistent emphasis on inflammatory disorders affecting joints and mobility.